NASDAQEquity · Weekly research terminal

NIKI

Niki BioSolutions, Inc.

US Healthcare Biotechnology

Latest week
7 Aug 2026
Weekly close
8.99 USD
Fair value
8.56 USD
Next-week expectancy
Positive 100.00%
SM Sharemaestro
Institutional Weekly Chart Pack Completed-week market evidence · Maximum 156 weeks

NASDAQ · Equity · United States

NIKI

Niki BioSolutions, Inc.

Healthcare Biotechnology

Niki BioSolutions, Inc., is a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.

Last updated
7 Aug 2026
Exchange
NASDAQ · NASDAQ
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Market capitalisation
7,565,500
Fair value reference
8.56
Next-week expectancy
Positive · 100.00%

Over the latest 12 completed weeks ending 2026-08-07, NIKI rose 28.43%, moving from 7.00 to 8.99. The latest weekly close is above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 4 weeks. Market Dynamics is 0.00 on the latest week. Next-week expectancy is positive at 100.00% based on similar historical setup states.

Week Ending
7 Aug 2026
Latest Close
8.99
12-Week Change
28.43%
Trend Signal
Inactive
Next-Week Expectancy
Positive 100.00%
Signal Weeks
0 of 4

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
7 Aug 2026
Latest Close
8.99
12-Week Change
28.43%
Trend Signal
Inactive
Next-Week Expectancy
Positive 100.00%
Signal Weeks
0 of 4
Vs Fair Value
Above
Market Dynamics
0.00

Over the latest 12 completed weeks ending 2026-08-07, NIKI rose 28.43%, moving from 7.00 to 8.99. The latest weekly close is above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 4 weeks. Market Dynamics is 0.00 on the latest week. Next-week expectancy is positive at 100.00% based on similar historical setup states.

Industry Peers

United States equities in Biotechnology

Stock Exchange Week Open High Low Close Change
CELZ Creative Medical Technology Holdings Inc NASDAQ 7 Aug 2026 0.67 1.94 0.62 1.42 113.53%
ENSC Ensysce Biosciences Inc NASDAQ 7 Aug 2026 0.25 0.98 0.25 0.52 110.69%
PEPG PepGen Ltd NASDAQ 7 Aug 2026 1.77 2.88 1.77 2.85 61.02%
IOVA Iovance Biotherapeutics Inc NASDAQ 7 Aug 2026 4.10 6.92 3.96 6.34 54.63%
OABI OmniAb Inc. NASDAQ 7 Aug 2026 2.01 3.12 1.94 3.08 53.23%
HELP Cybin Inc. Common Stock NASDAQ 7 Aug 2026 7.90 11.62 7.51 11.61 46.96%
CAI Caris Life Sciences, Inc. Common Stock NASDAQ 7 Aug 2026 15.92 22.77 15.84 22.74 42.84%
PYXS Pyxis Oncology Inc NASDAQ 7 Aug 2026 2.70 3.90 2.70 3.73 38.15%
VIVS VivoSim Labs, Inc. NASDAQ 7 Aug 2026 0.34 0.58 0.31 0.47 36.20%
SGMT Sagimet Biosciences Inc. Series A Common Stock NASDAQ 7 Aug 2026 6.74 9.09 6.50 9.06 34.42%
INSM Insmed Inc NASDAQ 7 Aug 2026 98.20 137.70 96.42 131.10 33.50%
FHTX Foghorn Therapeutics Inc NASDAQ 7 Aug 2026 4.55 6.17 4.47 6.07 33.41%
NXTC NextCure  Inc NASDAQ 7 Aug 2026 4.38 6.07 3.95 5.84 33.33%
IVVD Invivyd Inc. NASDAQ 7 Aug 2026 0.56 0.75 0.54 0.74 33.14%
ALGS Aligos Therapeutics Inc NASDAQ 7 Aug 2026 4.29 6.15 4.18 5.59 30.30%
QNCX Quince Therapeutics, Inc. NASDAQ 7 Aug 2026 23.51 30.77 23.50 30.20 28.48%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context